Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy.

The Journal of clinical investigation·2026
Same author

A case of early pregnancy pulmonary embolism following mifepristone administration: a call for increased pharmacovigilance and research.

Blood transfusion = Trasfusione del sangue·2026
Same author

Sudden bilateral ocular pain, conjunctival redness and blurred vision with halos at hemodialysis start: an eye of attention for the nephrologist! Lessons for the Clinical Nephrologist.

Journal of nephrology·2026
Same author

DPP-4 inhibitors in current diabetes care: their foundational role in treating to target.

Diabetes research and clinical practice·2026
Same author

Multidrug-Resistant Gram-Negative Urinary Tract Infections (UTIs) Increase the Risk of Rejection, CMV Viremia, and Graft Loss After Kidney Transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

JAMA network open·2026

Related Experiment Video

Updated: Jun 3, 2026

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
10:19

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing

Published on: February 13, 2016

Ultrafiltration in heart failure.

Enrico Fiaccadori1, Giuseppe Regolisti, Umberto Maggiore

  • 1Dipartimento di Clinica Medica, Nefrologia e Scienze della Prevenzione, Universita' degli Studi di Parma, Italy. enrico.fiaccadori@unipr.it

American Heart Journal
|March 12, 2011
PubMed
Summary
This summary is machine-generated.

Ultrafiltration (UF) offers rapid congestion relief in heart failure but isn't a diuretic substitute. It's best for advanced heart failure patients with diuretic resistance, not widespread use.

More Related Videos

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart
07:59

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart

Published on: June 20, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
10:19

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing

Published on: February 13, 2016

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart
07:59

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart

Published on: June 20, 2017

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Fluid overload is central to heart failure decompensation and progression.
  • It significantly contributes to hospital readmissions and worsens renal function, increasing mortality.
  • Ultrafiltration (UF) is explored as an alternative to diuretics for congestion relief.

Purpose of the Study:

  • To review the technical aspects, efficacy, safety, costs, and indications of UF in heart failure.
  • To evaluate UF's role compared to diuretic therapy in managing fluid overload.

Main Methods:

  • Systematic review of existing evidence on ultrafiltration in heart failure.
  • Analysis of UF's mechanisms, benefits, and limitations.

Main Results:

  • Current evidence does not support UF as a universal substitute for diuretics.
  • UF does not significantly impact electrolytes, azotemia, acid-base balance, or cytokine removal.
  • UF is not a rapid 'mechanical diuresis' or a solution for poor diuretic management.

Conclusions:

  • Ultrafiltration should be reserved for select advanced heart failure patients with diuretic resistance.
  • It should be part of a comprehensive fluid management strategy.
  • UF is not indicated for routine use or as a primary therapy over diuretics.